Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (2)
Azerbaijan (1)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Kazakhstan (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Russia (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
Thailand (1)
The Phillippines (1)
United Arab Emirates (1)
United Kingdom (3)
Uzbekistan (1)
30.08.2023
![People with Parkinson’s experience variations in effects of oral medicines, international survey reveals]()
12.07.2023
![STADA further grows its European Consumer Healthcare portfolio by acquiring several additional brands from Sanofi]()
01.06.2023
![STADA: FDA approves biologics facility to supply key medicine to patients in US]()
STADA: FDA approves biologics facility to supply key medicine to patients in US
Norbitec biotech facility in Uetersen, Germany, a company controlled by STADA, passes inspection by the US FDA
03.04.2023
![STADA and Xbrane launch ranibizumab to support patient access in Europe]()
STADA and Xbrane launch ranibizumab to support patient access in Europe
Ranibizumab biosimilar is being launched in major European markets
06.03.2023
![STADA sustains strong momentum with double-digit sales and profit growth in 2022]()
STADA sustains strong momentum with double-digit sales and profit growth in 2022
Full year 2022 results
